Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the Vibrance-2 dose-ranging phase 2 study evaluating alixorexton in patients with narcolepsy type 2 (NT2). Alixorexton, ...
Verde AgriTech Ltd (TSX: NPK | OTCQX: VNPKF) ("Verde” or the “Company”) announces its operating and financial results for the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈